Neovasc Inc. (NVCN:CA)

FDA Meeting is Scheduled for October

July 10, 2020
Report ID: 11568
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Neovasc Inc.
Neovasc Inc.
Healthcare
Medical Devices & Instruments
Ticker
NVCN:CA
Current Price
$40.15
Market Cap
$110.6M
Price Target
Refer to Report
Volume
4.9K
52wk Range
$6 - $41.2
Related Research Reports
2/10/2021

Complied with Nasdaq Minimum Bid Price Requirement
Complied with Nasdaq Minimum Bid Price Requirement (NVCN:CA)
10/22/2020

The FDA Panel to Decide on Reducer Commercialization in the US
The FDA Panel to Decide on Reducer Commercialization in the US (NVCN:CA)
7/10/2020

FDA Meeting is Scheduled for October
FDA Meeting is Scheduled for October (NVCN:CA)
5/27/2020

Neovasc Removes Financing Overhang
Neovasc Removes Financing Overhang (NVCN:CA)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.